by labtician-marketing | Oct 7, 2023 | Press Releases
DIAGNOS AI Retina Analysis is being deployed across Canada’s Largest Specialist Care Provider in Diabetes & Endocrinology October 5, 2023 (Brossard, Québec, Canada) – DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a Canadian...
by labtician-marketing | May 10, 2022 | Press Releases
Canadian Eye Care Professionals and their Patients to Benefit from Innovative New Services, Increased Support, and Best-in-Class Products Oakville, ON: May 10th 2022 – As two world-class family companies with a passion for eye care, Laboratoires Théa and Labtician...
by labtician-marketing | Mar 16, 2022 | Press Releases
CAN Health Network and Quebec-Based DIAGNOS Announce Life-Changing Diabetic Retinopathy Screening Program Partnership Innovative diabetic retina screening service resulting in earlier intervention, better care, and savings to the Canadian healthcare system. March 15,...
by labtician-marketing | Mar 3, 2021 | Press Releases
DIAGNOS Announces its Exclusive Strategic Partnership Agreement with Labtician Ophthalmics, a Leader in Canadian and International Eyecare Markets to Address Growing Needs in the Monitoring of Diabetic and Hypertensive Patients Brossard, Quebec, Canada – February 24,...
